Lucid Diagnostics (LUCD) Retained Earnings (2020 - 2026)
Lucid Diagnostics' (LUCD) quarterly Retained Earnings came in at -$298.0 million in Q1 2026, down 24.26% YoY from -$393.4 million in Q1 2025, and down 8.61% on a QoQ basis from -$274.3 million in Q4 2025.
Lucid Diagnostics (LUCD) Retained Earnings (2020 - 2026) Analysis & Trends
Lucid Diagnostics (LUCD) has 7 years of Retained Earnings data on file, last reported at -$298.0 million in Q1 2026.
- Quarterly Retained Earnings fell 24.26% year-over-year to -$298.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$298.0 million (down 24.26% YoY) and the FY2025 annual result came in at -$274.3 million, down 34.63% from the prior year.
- Retained Earnings fell to -$298.0 million in Q1 2026, from -$274.3 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $201.0 million in Q2 2025 to a low of -$298.0 million in Q1 2026.
- A 5-year average of -$54.5 million and a median of -$83.1 million in 2022 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2022 — Retained Earnings surged 388.95% — and 2025, when it sank 280.98%.
- Tracing LUCD's Retained Earnings over 5 years: stood at $121.1 million in 2022, then sank by 224.5% to -$150.7 million in 2023, then plunged by 35.18% to -$203.8 million in 2024, then tumbled by 34.63% to -$274.3 million in 2025, then fell by 8.61% to -$298.0 million in 2026.
- The last three Retained Earnings figures came in at -$298.0 million (Q1 2026), -$274.3 million (Q4 2025), and -$258.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 49.79 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 21.82 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 32.64 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 7.82 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 14.86 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.88 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 6.78 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 3.15 Bn |
| 10 | Lucid Diagnostics | 175.80 Mn | 142.40 Mn | 55,000.00 | 323.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 323.41 Mn |
| Mar 31, 2026 | -297.96 Mn |
| Dec 31, 2025 | -274.34 Mn |
| Sep 30, 2025 | -258.07 Mn |
| Jun 30, 2025 | 201.01 Mn |
| Mar 31, 2025 | -239.78 Mn |
| Dec 31, 2024 | -203.77 Mn |
| Sep 30, 2024 | 142.59 Mn |
| Jun 30, 2024 | -179.85 Mn |
| Mar 31, 2024 | 136.41 Mn |
| Dec 31, 2023 | -150.74 Mn |
| Sep 30, 2023 | 128.80 Mn |
| Jun 30, 2023 | -125.70 Mn |
| Mar 31, 2023 | 125.56 Mn |
| Dec 31, 2022 | 121.08 Mn |
| Sep 30, 2022 | -83.15 Mn |
| Jun 30, 2022 | -68.80 Mn |
| Mar 31, 2022 | 100.63 Mn |
| Dec 31, 2021 | -41.90 Mn |
| Sep 30, 2021 | -30.60 Mn |